Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronen Loebstein

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
World Journal of Gastroenterology|February 17, 2015
Significance of low level infliximab in the absence of anti-infliximab antibodiesBella Ungar, Adi Anafy, Henit Yanai, et al.
The Israel Medical Association Journal : IMAJ|February 25, 2026
Massive Honeybee Envenomation: A Case Series of Simultaneous Multiple CasualtiesAmir Givon, Rotem Tal-Ben Ishay, Lior Naveh, et al.
Medicine|May 8, 2015
Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failureBella Ungar, Ola Haj-Natour, Uri Kopylov, et al.
Journal of Crohn'S & Colitis|September 1, 2018
Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal StrategiesShomron Ben-Horin, Gert Van Assche, Yehuda Chowers, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
World Journal of Gastroenterology|February 17, 2015
Significance of low level infliximab in the absence of anti-infliximab antibodiesBella Ungar, Adi Anafy, Henit Yanai, et al.
The Israel Medical Association Journal : IMAJ|February 25, 2026
Massive Honeybee Envenomation: A Case Series of Simultaneous Multiple CasualtiesAmir Givon, Rotem Tal-Ben Ishay, Lior Naveh, et al.
Medicine|May 8, 2015
Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failureBella Ungar, Ola Haj-Natour, Uri Kopylov, et al.
Journal of Crohn'S & Colitis|September 1, 2018
Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal StrategiesShomron Ben-Horin, Gert Van Assche, Yehuda Chowers, et al.
Pageof 7